# Statistical Approaches to Establishing Bioequivalence - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/statistical-approaches-to-establishing-bioequivalence/ecbc1c62-e39f-4980-b654-baa7788c2171

> FDA guidance document: Statistical Approaches to Establishing Bioequivalence. Issue date: December 02, 2022. Get complete insights and analysis.

---

## Details

- Title: Statistical Approaches to Establishing Bioequivalence
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-12-02
- Last Changed: 2023-01-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0197">FDA-2001-D-0197</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Pulmonary Tuberculosis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/pulmonary-tuberculosis-developing-drugs-for-treatment/8b46de55-ddca-4887-a2ad-5d46be5633aa)
- [Data Integrity for In Vivo Bioavailability and Bioequivalence Studies](https://www.globalkeysolutions.net/guidances/guidance-document/data-integrity-for-in-vivo-bioavailability-and-bioequivalence-studies/04d979b3-3f1d-4515-b9c1-f1a8fb7fb19b)